Related Experiment Video

Updated: Jun 19, 2026

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
12:43

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption

Published on: August 16, 2016

Cardiac biomarkers in a model of acute catecholamine cardiotoxicity

Premysl Mladenka1, Radomír Hrdina, Zuzana Bobrovová

  • 1Department of Pharmacology and Toxicology, Charles University in Prague, Hradec Králové, Czech Republic. mladenkap@faf.cuni.cz

Human & Experimental Toxicology
|October 9, 2009
PubMed

Insights

This study shows that isoprenaline causes myocardial injury in rats, linked to calcium overload. Understanding this model helps explore treatments for acute myocardial infarction (AMI).

Area of Science:

  • Cardiology
  • Toxicology
  • Biochemistry

Background:

  • Coronary heart disease is a leading cause of mortality globally.
  • Acute myocardial infarction (AMI) is its most severe manifestation.
  • Understanding AMI's mechanisms is crucial for improving patient prognosis.

Purpose of the Study:

  • To investigate the etiopathogenetic mechanisms of myocardial injury using a catecholamine model.
  • To explore the role of calcium overload and oxidative stress in isoprenaline-induced myocardial damage.

Main Methods:

  • Male Wistar:Han rats were divided into control (saline) and isoprenaline (ISO) groups.
  • Functional parameters, blood biochemical markers, and heart tissue metal content were analyzed 24 hours post-administration.
  • Histological examination was performed to assess myocardial damage.

Main Results:

  • ISO administration induced significant myocardial injury, characterized by calcium overload.
  • A strong correlation was observed between myocardial impairment markers (serum TnT, stroke volume index, ventricle weight) and myocardial calcium levels.
  • While reactive oxygen species (ROS) showed a non-significant increase, copper levels in heart tissue significantly increased in the ISO group.

Conclusions:

  • The isoprenaline model effectively replicates aspects of human AMI, highlighting calcium overload as a key factor in myocardial injury.
  • This model provides insights into the biochemical and elemental changes associated with acute cardiac damage.
  • Further research may utilize this model to develop targeted therapies for AMI.

More Related Videos

Acute Myocardial Infarction in Rats07:45

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...